Cargando…
Study protocol for a phase II, double-blind, randomised controlled trial of cannabidiol (CBD) compared with placebo for reduction of brain neuroinflammation in adults with chronic low back pain
INTRODUCTION: Chronic pain is a debilitating medical problem that is difficult to treat. Neuroinflammatory pathways have emerged as a potential therapeutic target, as preclinical studies have demonstrated that glial cells and neuroglial interactions play a role in the establishment and maintenance o...
Autores principales: | Pike, Chelsea K, Kim, Minhae, Schnitzer, Kristina, Mercaldo, Nathaniel, Edwards, Robert, Napadow, Vitaly, Zhang, Yi, Morrissey, Erin Janas, Alshelh, Zeynab, Evins, A Eden, Loggia, Marco L, Gilman, Jodi M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9486315/ https://www.ncbi.nlm.nih.gov/pubmed/36123113 http://dx.doi.org/10.1136/bmjopen-2022-063613 |
Ejemplares similares
-
The pandemic brain: Neuroinflammation in non-infected individuals during the COVID-19 pandemic
por: Brusaferri, Ludovica, et al.
Publicado: (2022) -
Cannabidiol (CBD) in Cancer Management
por: O’Brien, Kylie
Publicado: (2022) -
Towards Better Delivery of Cannabidiol (CBD)
por: Millar, Sophie Anne, et al.
Publicado: (2020) -
Cannabidiol (CBD) and Insomnia : Literature review
por: Gutierrez Higueras, T., et al.
Publicado: (2022) -
The use of cannabidiol (CBD) as an analgesic component
por: Petersen, Kristian Kjær-Staal, et al.
Publicado: (2023)